Showing results (11-20 of 273) with videos related to
Sort By:
Pageof 28
American Journal of Physiology. Heart and Circulatory Physiology|November 26, 2008
Antiatherosclerotic effect of farnesoid X receptorAndrea Mencarelli, Barbara Renga, Eleonora Distrutti, et al.Liver Research (Beijing, China)|April 10, 2025
Bile acids and their receptors in hepatic immunityStefano Fiorucci, Silvia Marchianò, Eleonora Distrutti, et al.World Journal of Gastroenterology|February 23, 2016
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesEleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, et al.Expert Opinion on Therapeutic Patents|April 14, 2018
Farnesoid X receptor modulators 2014-present: a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.Expert Opinion on Therapeutic Patents|July 18, 2015
Farnesoid X receptor modulators (2011 - 2014): a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.Gastroenterology|July 13, 2006
The emerging roles of hydrogen sulfide in the gastrointestinal tract and liverStefano Fiorucci, Eleonora Distrutti, Giuseppe Cirino, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
The bile acid receptor FXR is a modulator of intestinal innate immunityPiero Vavassori, Andrea Mencarelli, Barbara Renga, et al.Future Medicinal Chemistry|July 2, 2015
Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical applicationValentina Sepe, Eleonora Distrutti, Vittorio Limongelli, et al.Trends in Molecular Medicine|June 26, 2007
Targeting farnesoid X receptor for liver and metabolic disordersStefano Fiorucci, Gianni Rizzo, Annibale Donini, et al.World Journal of Gastroenterology|May 7, 2009
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculationBarbara Renga, Andrea Mencarelli, Marco Migliorati, et al.Pageof 28